XML 34 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2015
Investments in Debt Securities

Investments in debt securities consisted of the following at December 31, 2015 (in thousands):

 

     December 31, 2015  
     Amortized
Cost
     Gross
Unrealized
Gain
     Gross
Unrealized
Loss
    Fair
Value
 

Marketable securities:

          

U.S. Government and agency securities

   $ 7,029       $ —         $ (6   $ 7,023   

Corporate and other debt securities

     10,659         7         (7     10,659   
  

 

 

    

 

 

    

 

 

   

 

 

 
     17,688         7         (13     17,682   

Long-term marketable securities:

          

U.S. Government and agency securities

     838         —           (2     836   

Corporate and other debt securities

     800         —           (3     797   
  

 

 

    

 

 

    

 

 

   

 

 

 
     1,638         —           (5     1,633   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total

   $ 19,326       $ 7       $ (18   $ 19,315   
  

 

 

    

 

 

    

 

 

   

 

 

 

 

Investments in debt securities consisted of the following at December 31, 2014 (in thousands):

 

     December 31, 2014  
     Amortized
Cost
     Gross
Unrealized
Gain
     Gross
Unrealized
Loss
    Fair Value  

Marketable securities:

          

U.S. Government and agency securities

   $ 12,716       $ 2       $ (2   $ 12,716   

Corporate and other debt securities

     10,373         4         (3     10,374   
  

 

 

    

 

 

    

 

 

   

 

 

 
     23,089         6         (5     23,090   

Long-term marketable securities:

          

U.S. Government and agency securities

     1,228         —           —          1,228   

Corporate and other debt securities

     2,326         —           (4     2,322   
  

 

 

    

 

 

    

 

 

   

 

 

 
     3,554         —           (4     3,550   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total

   $ 26,643       $ 6       $ (9   $ 26,640   
  

 

 

    

 

 

    

 

 

   

 

 

 
Contractual Maturities of Debt Securities

The contractual maturities of debt securities at December 31, 2015 were as follows (in thousands):

 

     Amortized
Cost
     Fair Value  

Due in 1 year or less

   $ 17,688       $ 17,682   

Due in 1 to 2 years

     1,638         1,633   
  

 

 

    

 

 

 
   $ 19,326       $ 19,315   
  

 

 

    

 

 

 
Assets Measured at Fair Value on Recurring Basis

The following fair value hierarchy table presents information about each major category of the Company’s assets measured at fair value on a recurring basis as of December 31, 2015 (in thousands):

 

     Fair value measurement at reporting date using:  
     Quoted prices in
active markets for
identical assets
(Level 1)
     Significant
other observable
inputs
(Level 2)
     Significant
unobservable
inputs
(Level 3)
     Total  

Assets:

           

Money market funds

   $ 12,685       $ —         $ —         $ 12,685   

U.S. Government and agency securities

     7,456         402         —           7,858   

Corporate and other debt securities

     —           11,457         —           11,457   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 20,141       $ 11,859       $ —         $ 32,000   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           

Contingent consideration – short-term

     —           —           4,480         4,480   

Contingent consideration – long-term

     —           —           2,308         2,308   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —         $ —         $ 6,788       $ 6,788   
  

 

 

    

 

 

    

 

 

    

 

 

 
Quantitative Information Associated with Fair Value Measurement of Contingent Consideration Related to Refine Using Level 3 Inputs

The following tables provide quantitative information associated with the fair value measurement of the Company’s contingent consideration related to Refine using Level 3 inputs (in thousands):

 

     Contingent Consideration
     Refine

Fair value as of December 31, 2015

   $ 6,369

Valuation technique

   Probability-adjusted

discounted cash flow

Periods in which milestones can be achieved

   2015 – 2016

 

      Fixed
Earn-out
     Variable
Earn-out
     Accrued
Balance
 

2015

   $ 3,500         850       $ 4,350   

2016

     4,250         1,300         2,019   
Roll Forward of Fair Value of Contingent Consideration

The following table provides a rollforward of the fair value of the contingent consideration (in thousands):

 

Balance at December 31, 2014

   $ 3,844   

Payments

     (1,139

Changes in fair value

     4,083   
  

 

 

 

Balance at December 31, 2015

   $ 6,788   
  

 

 

 
Schedule of Inventories

Inventories consist of the following (in thousands):

 

     December 31,
2015
     December 31,
2014
 

Raw Materials

   $ 10,671       $ 5,374   

Work-in-process

     1,586         2,256   

Finished products

     5,741         4,754   
  

 

 

    

 

 

 

Total

   $ 17,998       $ 12,384   
  

 

 

    

 

 

 
Reconciliation of Basic and Diluted Shares Amounts

A reconciliation of basic and diluted share amounts is as follows:

 

     Years ended December 31,  
     2015      2014      2013  

Numerator:

        

Net income

   $ 9,345,000       $ 8,170,000       $ 16,093,000   

Denominator:

        

Basic weighted average common shares outstanding

     32,881,940         32,497,657         31,667,015   

Weighted average common stock equivalents from assumed exercise of stock options and restricted stock awards

     695,151         766,010         739,626   
  

 

 

    

 

 

    

 

 

 

Diluted weighted average common shares outstanding

     33,577,091         33,263,667         32,406,641   
  

 

 

    

 

 

    

 

 

 

Basic net income per common share

   $ 0.28       $ 0.25       $ 0.51   
  

 

 

    

 

 

    

 

 

 

Diluted net income per common share

   $ 0.28       $ 0.25       $ 0.50   
  

 

 

    

 

 

    

 

 

 
Total Assets by Geographic Area

The following table represents the Company’s total assets by geographic area (in thousands):

 

     December 31,
2015
     December 31,
2014
 

United States

   $ 91,881       $ 83,785   

Sweden

     54,313         44,508   

Singapore

     43         —     
  

 

 

    

 

 

 

Total

   $ 146,237       $ 128,293   
  

 

 

    

 

 

 
Long Lived Assets by Geographic Area

The following table represents the Company’s long-lived assets by geographic area (in thousands):

 

     December 31,
2015
     December 31,
2014
 

United States

   $ 36,350       $ 38,695   

Sweden

     6,635         8,653   
  

 

 

    

 

 

 

Total

   $ 42,985       $ 47,348   
  

 

 

    

 

 

 
Percentage of Revenue from Significant Customers

Revenue from significant customers as a percentage of the Company’s total revenue is as follows:

 

     Years ended December 31,  
     2015     2014     2013  

Orencia® Royalties from Bristol

     —          —          27

GE Healthcare

     37     38     35

MilliporeSigma

     29     33     25
Intangible assets

Intangible assets consisted of the following at December 31, 2015 (in thousands):

 

     Gross Carrying
Amount
     Accumulated
Amortization
    Weighted
Average
Useful Life
(in years)
 

Technology – developed

   $ 3,295       $ (1,026     12   

In process research and development

     1,600         —          —     

Patents

     240         (177     8   

Customer relationships

     11,805         (3,682     9   

Trademark/ tradename

     700         —          —     
  

 

 

    

 

 

   

 

 

 

Total intangible assets

   $ 17,640       $ (4,885     10   
  

 

 

    

 

 

   

 

Intangible assets consisted of the following at December 31, 2014 (in thousands):

 

     Gross Carrying
Amount
     Accumulated
Amortization
    Weighted
Average
Useful Life
(in years)
 

Technology – developed

   $ 3,338       $ (750     12   

In process research and development

     1,600         —          —     

Patents

     240         (148     8   

Customer relationships

     12,202         (2,546     9   

Trademark/ tradename

     700         —          —     
  

 

 

    

 

 

   

 

 

 

Total intangible assets

   $ 18,080       $ (3,444     10   
  

 

 

    

 

 

   
Schedule of Amortization Expense for Amortized Intangible Assets

As of December 31, 2015, the Company expects to record the approximate amortization expense (in thousands):

 

Years Ending

   Amortization Expense  

December 31, 2016

   $ 1,701   

December 31, 2017

     1,701   

December 31, 2018

     1,537   

December 31, 2019

     1,522   

December 31, 2020

     1,189   
Total Revenue  
Percentage by Geographic Area or Significant Customers

The following table represents the Company’s total revenue by geographic area (based on the location of the customer):

 

     Years ended December 31,  
     2015     2014     2013  

Sweden

     37     38     35

United States

     28     33     51

United Kingdom

     17     20     12

Other

     18     9     2
  

 

 

   

 

 

   

 

 

 

Total

     100     100     100
  

 

 

   

 

 

   

 

 

 
Accounts Receivable  
Percentage by Geographic Area or Significant Customers

Significant accounts receivable balances as a percentage of the Company’s total trade accounts receivable and royalties and other receivable balances are as follows:

 

     December 31, 2015     December 31, 2014  

GE Healthcare

     13     29

MilliporeSigma

     32     7

Bioprocessing Customer C

     21     —     

Bioprocessing Customer D

     —          11